Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement about the cumulative addition of loans.
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement Regarding the Repurchase Results of "Nortel Convertible Bonds"
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement regarding the signing of supplementary agreements to the three-party supervision agreement for the storage of funds raised.
Jiangsu Sinopep-Allsino Biopharmaceutical: Third prompt announcement regarding the optional redemption of Nortai Convertible Bonds.
Jiangsu Sinopep-Allsino Biopharmaceutical: The second optional redemption reminder for the 'Notai Convertible Bond.'
Jiangsu Sinopep-Allsino Biopharmaceutical: The first prompt announcement on the redemption of "Nortai Convertible Bonds".
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement on Proposal of Interim Dividend and Implementation of the 2024 'Improving Quality and Efficiency, Returning Benefits' Special Action Plan by the Controlling Shareholder and Actual Controller
Legal Opinion of Guohao Law Firm (Hangzhou) on the First Extraordinary General Meeting of Shareholders of Jiangsu Nuo Tai Ausino Pharmaceutical Co., Ltd. in 2024
Legal Opinion of Guohao Law Firm (Hangzhou) Regarding the 2024 First Bondholders' Meeting of Jiangsu NuoTaiAusen Bio pharmaceutical Co., Ltd.'s NuoTai Convertible Bonds.
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement of the resolution of the first bondholders meeting of the ‘Nuotai Convertible Bonds’ in 2024.
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement Regarding the Special Action Plan for “Improvement, Efficiency Enhancement and Return” in 2024.
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement regarding the redemption of "Notaï Convertible Bonds".
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement Regarding Non-Preemptive Redemption of "Note Convertible Bonds"
Nanjing Securities Co., Ltd.'s verification opinion on Jiangsu Notai Ausino Biopharmaceutical Co., Ltd.'s non-early redemption of "Notai Convertible Bonds".
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement on voluntary disclosure of the production line of new oral solid dosage form workshop and hard capsule dosage form passing the pharmaceutical GMP compliance inspection.
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement of the results of the first vesting period of the 2023 Restricted Stock Incentive Plan and the listing of shares.
Jiangsu Sinopep-Allsino Biopharmaceutical: Meeting material for the first bondholder meeting of the "Notai Convertible Bonds" in 2024.
Jiangsu Sinopep-Allsino Biopharmaceutical: Materials for the first ad-hoc shareholders' meeting in 2024.
Jiangsu Sinopep-Allsino Biopharmaceutical: Announcement on the Expected Redemption Conditions of "Notai Convertible Bonds".
No Data